Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
By LabMedica International staff writers Posted on 13 Jan 2022 |
The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.
These are the latest findings of Transparency Market Research (Albany NY, USA), a market intelligence provider.
Coagulation is a process wherein certain proteins and blood cells together create a gel-like clot to stop bleeding from a damaged or leaking blood vessel. Coagulometer is a device that is used to evaluate the efficiency of blood factors to form a clot. Coagulometers are widely used across the globe to diagnose hemophilia and other genetic hematological diseases. They are also used to monitor the progression of treatment with anti-coagulants in affected patients. These devices detect the time taken for coagulation in an ambient environment. Before the introduction of semi-automated and automated coagulation analyzers, these tests were performed manually. They involved high cost, skilled labor, and high probability of errors.
There has been rise in the incidence and prevalence of blood disorders such as hemophilia over the last few years. This high prevalence of blood disorders is estimated to drive the demand for more diagnostic tools, which in turn, is likely to propel the growth of the global coagulometers market. Moreover, the rising consumption of anti-coagulant drugs such as aspirin and heparin that necessitates the use of coagulometers to monitor the treatment progress in those patients is also fueling market growth. However, the high cost of these devices is diverting potential users towards manual coagulation testing, which is expected to restrain the growth of the global coagulometers market.
Based on technology, the global coagulometers market is dominated by the photo-optical detection and electrochemical detection segments which hold the highest market share as most automated coagulometers work on the principle of photo-optical or electrochemical detection. Based on channel type, the multichannel coagulometers segment holds the largest share in the global coagulometers market as multichannel coagulometers are widely used in diagnostic laboratories and hospitals. Based on end-user, the hospitals & diagnostic laboratories segment is expected to account for a major share of the global coagulometers market.
Geographically, North America is expected to hold a major share of the global coagulometers market, owing to high adoption of technology and high expenditure on health care by public and private sectors in the region. Europe is anticipated to account for a significant share of the global coagulometers market due to the high prevalence of blood disorders in the region. Local governing bodies in Asia Pacific are investing in the development of health care facilities and academic research institutes in the region, which is projected to propel the market for coagulometers in the region.
Related Links:
Transparency Market Research
Latest Industry News
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus